(Q37825856)

English

Confiscated black market products and nutritional supplements with non-approved ingredients analyzed in the Cologne Doping Control Laboratory 2009.

scientific article published on 26 October 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1 reference

Europe PubMed Central

Confiscated black market products and nutritional supplements with non-approved ingredients analyzed in the Cologne Doping Control Laboratory 2009. (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

6

object named as

Mario Thevis

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Wilhelm Schänzer

5

object named as

Wilhelm Schänzer

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1

object named as

Maxie Kohler

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

author name string

Andreas Thomas

2

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Hans Geyer

3

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Michael Petrou

4

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

publication date

26 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Drug Testing and Analysis

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

11-12

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

533-537

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Analysis of confiscated black market drugs using chromatographic and mass spectrometric approaches

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

21 January 2018

Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

21 January 2018

Changes in appetite and body weight in response to long-term oral administration of the ghrelin agonist GHRP-2 in growth hormone deficient children

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

21 January 2018

Athletes' "designer steroid" leads to widening scandal

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Tetrahydrogestrinone: discovery, synthesis, and detection in urine

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of chemically modified steroids for doping control purposes by electrospray ionization tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of illegal trade on the quality of epoetin alfa in Thailand.

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Nutritional supplements cross-contaminated and faked with doping substances

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Counterfeiting in performance- and image-enhancing drugs

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I) and an analogue LR3IGF-I in pregnant rats

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I), IGF-II and des(1-3)IGF-I in rats

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Making the most of affinity tags

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Affinity as a tool in life science

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Growth hormone-releasing peptides: clinical and basic aspects

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Emerging drugs--potential for misuse in sport and doping control detection strategies

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Comprehensive plasma-screening for known and unknown substances in doping controls

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Screening for 2-quinolinone-derived selective androgen receptor agonists in doping control analysis

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Screening for two selective androgen receptor modulators using gas chromatography-mass spectrometry in doping control analysis

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Mass spectrometry of hydantoin-derived selective androgen receptor modulators

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of benzimidazole- and bicyclic hydantoin-derived selective androgen receptor antagonists and agonists in human urine using LC-MS/MS.

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

High-sensitivity chemiluminescence immunoassays for detection of growth hormone doping in sports

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Test method: GH.

1 reference

https://api.crossref.org/works/10.1002%2FDTA.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DTA.186

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37825856&oldid=2120913674"